Resultado de búsqueda
Ben Michael Goldacre OBE (born 20 May 1974) is a British physician, academic and science writer. He is the first Bennett Professor of Evidence-Based Medicine and director of the Bennett Institute for Applied Data Science at the University of Oxford.
- Bad Pharma
Bad Pharma: How Drug Companies Mislead Doctors and Harm...
- Bad Science (Goldacre book)
Bad Science is a book written by Ben Goldacre which...
- Bad Pharma
Mala ciencia, es un libro de Ben Goldacre que critica la forma en la que los medios de comunicación cubren las noticias sobre sanidad y ciencia. Publicado originalmente en septiembre de 2008, 1 el libro contiene versiones extendidas y revisadas de muchas de sus columnas en The Guardian.
Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by the British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products.
Bad Science is a book written by Ben Goldacre which criticises certain physicians and the media for a lack of critical thinking and misunderstanding of evidence and statistics which is detrimental to the public understanding of science.
Bennett Professor of Evidence-Based Medicine Director of Bennett Institute for Applied Data Science. Ben is a doctor, academic, writer, and broadcaster. He trained in medicine at Oxford and UCL, in psychiatry at the Maudsley, and in epidemiology at LSHTM.
Research Groups. Bennett Institute for Applied Data Science. Ben Goldacre. Director of Bennett Institute for Applied Data Science. Ben is a doctor, academic, writer, and broadcaster. He trained in medicine at Oxford and UCL, in psychiatry at the Maudsley, and in epidemiology at LSHTM.
20 de jul. de 2016 · Debunker. Home: alltrials.net Website: Bad Science Book: Bad Science. TED Speaker. Personal profile. Ben Goldacre unpicks dodgy scientific claims made by scaremongering journalists, dubious government reports, pharmaceutical corporations, PR companies and quacks. Why you should listen.
